# why-does-type-1-diabeted-mellitus-most-often-occur-in-children

## **SkellyBot**:

 [message link](https://discord.com/channels/1194766712680222800/1212980287575826443/1212982469331255348) 

 Certainly! Here's a brief overview of some companies working on Type 1 diabetes (T1D) therapies and their strategies:

### ViaCyte, Inc.
- **Therapeutic Strategy**: Developing stem cell-derived islet cell replacement therapies.
- **Notable Therapy**: PEC-Direct, an implantable device containing pancreatic progenitor cells that mature into insulin-producing cells in the body.

### Vertex Pharmaceuticals
- **Therapeutic Strategy**: Focusing on stem cell-derived, fully differentiated, insulin-producing islet cells.
- **Notable Therapy**: VX-880, an investigational stem cell-derived, fully differentiated pancreatic islet cell replacement therapy.

### CRISPR Therapeutics
- **Therapeutic Strategy**: Utilizing CRISPR/Cas9 for gene editing to develop immune-evasive cells.
- **Notable Collaboration**: Partnering with ViaCyte to develop CRISPR-edited stem cell-derived therapies.

### Semma Therapeutics (acquired by Vertex Pharmaceuticals)
- **Therapeutic Strategy**: Specializing in cell therapy, with a focus on stem cell-derived islet cells for transplantation.
- **Notable Therapy**: Now part of Vertex's pipeline after acquisition.

### DompÃ©
- **Therapeutic Strategy**: Biopharmaceutical approach with a focus on regenerative medicine.
- **Notable Therapy**: Rh-NGF (nerve growth factor), which has potential regenerative properties for beta cells.

These companies represent a cross-section of the innovative work being done in the field of T1D therapy development. Their approaches vary, with some focusing on cell replacement and regeneration and others on genetic editing to either protect existing cells or change immune system behavior. This information can serve as a starting point for deeper research into potential therapies for your capicture project.

## **kendrickm**:

 [message link](https://discord.com/channels/1194766712680222800/1212980287575826443/1212982466189598760) 

 Can you give me names of companies working on T1D therapies along with their therapeutic strategy?

## **SkellyBot**:

 [message link](https://discord.com/channels/1194766712680222800/1212980287575826443/1212982251336507402) 

 Yes, there are biotech companies and research institutions investigating the potential of gene editing technologies, such as CRISPR/Cas9, to develop therapies for Type 1 diabetes (T1D). These efforts are often aimed at:

- **Editing Immune Cells**: Modifying the patient's immune cells to prevent them from attacking beta cells.
- **Beta Cell Regeneration**: Altering pancreatic cells or stem cells to regenerate or replace the destroyed beta cells.
- **Protecting Beta Cells**: Making beta cells more resistant to autoimmune attacks.

However, these approaches are still in the experimental stages and face various challenges, including ensuring targeted and safe edits and translating these therapies from the lab to clinical practice. It's a highly dynamic field, and staying updated with the latest developments could be a valuable aspect of your capacity as a researcher in your capstone project.

## **kendrickm**:

 [message link](https://discord.com/channels/1194766712680222800/1212980287575826443/1212982249612517428) 

 are there any biotech companies focusing on using gene editing to create a therapy for T1D?

## **SkellyBot**:

 [message link](https://discord.com/channels/1194766712680222800/1212980287575826443/1212980832013389924) 

 Once the beta cells in the pancreas have been destroyed by the autoimmune process characteristic of Type 1 diabetes, they do not typically regenerate or grow back. This is a key reason why individuals with Type 1 diabetes are dependent on insulin therapy for life to regulate their blood sugar levels. 

Current research, including stem cell therapy and beta cell regeneration, is exploring ways to stimulate the growth of new beta cells or to transplant beta cells, but these are not yet standard treatments and are still under investigation. Your research proposal could potentially explore these avenues or focus on the prevention of beta cell destruction in the first place.

## **kendrickm**:

 [message link](https://discord.com/channels/1194766712680222800/1212980287575826443/1212980830348251157) 

 after the beta cells in the pancreas have been destroyed by the autoimmune destruction, do they grow back?

## **SkellyBot**:

 [message link](https://discord.com/channels/1194766712680222800/1212980287575826443/1212980298912895046) 

 Type 1 diabetes mellitus often manifests in childhood, although it can occur at any age, due to a combination of genetic and environmental factors that lead to the autoimmune destruction of insulin-producing beta cells in the pancreas. Here's a brief overview of why children are commonly affected:

- **Genetic Susceptibility**: Certain genes, particularly those associated with the human leukocyte antigen (HLA) system, increase the risk of developing Type 1 diabetes. These genes are inherited, and when they are present, the risk of developing the condition is higher.

- **Autoimmune Reaction**: Type 1 diabetes is an autoimmune condition where the body's immune system mistakenly attacks and destroys the insulin-producing beta cells. This process may be triggered by an environmental factor, such as a viral infection, particularly in those who are genetically predisposed.

- **Rapid Immune Response**: Children's immune systems are very active and responsive. When a triggering event occurs, such as a viral infection, the immune system may react aggressively, which can lead to a quicker onset of Type 1 diabetes compared to adults.

- **Developmental Stage**: During childhood, the body is growing and changing rapidly, which may make the beta cells more susceptible to attack or could contribute to the immune system mistaking them for foreign invaders.

Understanding why Type 1 diabetes often occurs in children is a significant aspect of research and can play a crucial role in your capstone project, as it may influence the direction of your research proposal, particularly when considering the interaction between HLA alleles and islet antigens.

## **SkellyBot**:

 [message link](https://discord.com/channels/1194766712680222800/1212980287575826443/1212980293888376832) 

 Starting new chat with initial message:

> why does type 1 diabeted mellitus most often occur in children?

![chat-1212980287575826443.json](https://cdn.discordapp.com/attachments/1212980287575826443/1212982583231774730/chat-1212980287575826443.json?ex=660f808f&is=65fd0b8f&hm=4d13a3f4ab2054acf550152c4d605d0ae7cc9f0c3e663b2d12efbb4c5477bac6&)

## **SkellyBot**:

 [message link](https://discord.com/channels/1194766712680222800/1212980287575826443/1212980289098227762) 

 

